JOHN NPAPADOPOULOSJOHN N PAPADOPOULOS8577PAPADOPOULOS, JOHN NAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson19770 Kingsland BlvdKaty77094-1031TXGynecological Oncology & Reproductive MedicineInfectious Diseases, Infection Control, and Employee HealthLeukemiaMD AndersonDIMITRIOS PKONTOYIANNISDIMITRIOS P KONTOYIANNIS8761KONTOYIANNIS, DIMITRIOS PProfessorASHISHKAMATASHISH KAMAT8961KAMAT, ASHISHProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorPATRICIATRONCOSOPATRICIA TRONCOSO8504TRONCOSO, PATRICIAProfessor0.6382940.00728999155research areas0.8340780.021537143coauthor of35.62672.7389560similar to1118selected publicationsSURENAMATINSURENA MATIN9030MATIN, SURENAProfessorMARK SEUNGWOOKKIMMARK SEUNGWOOK KIM9138KIM, MARK SEUNGWOOKAssistant ProfessorVICTOR JOSEPHHASSIDVICTOR JOSEPH HASSID9831HASSID, VICTOR JOSEPHAssistant ProfessorCURTIS APETTAWAYCURTIS A PETTAWAY8468PETTAWAY, CURTIS AProfessorGUILLERMOGARCIA-MANEROGUILLERMO GARCIA-MANERO8853GARCIA-MANERO, GUILLERMOProfessorAuthorship 2260334Authorship 229174319012911Mathew P, Pisters LL, Wood CG, Papadopoulos JN, Williams DL, Thall PF, Wen S, Horne E, Oborn CJ, Langley R, Fidler IJ, Pettaway CAThe Journal of urologyNeoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer. J Urol. 2009 Jan; 181(1):81-7; discussion 87.J Urol2008-11-13T00:00:002008Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer.21251905Kim SW, Kim JS, Papadopoulos J, Choi HJ, He J, Maya M, Langley RR, Fan D, Fidler IJ, Kim SJInternational immunopharmacologyConsistent interactions between tumor cell IL-6 and macrophage TNF-a enhance the growth of human prostate cancer cells in the bone of nude mouse. Int Immunopharmacol. 2011 Jul; 11(7):862-72.Int Immunopharmacol2011-01-18T00:00:002011Consistent interactions between tumor cell IL-6 and macrophage TNF-a enhance the growth of human prostate cancer cells in the bone of nude mouse.Authorship 2517003Authorship 257309319349357Kim SJ, Kim JS, Papadopoulos J, Wook Kim S, Maya M, Zhang F, He J, Fan D, Langley R, Fidler IJThe American journal of pathologyCirculating monocytes expressing CD31: implications for acute and chronic angiogenesis. Am J Pathol. 2009 May; 174(5):1972-80.Am J Pathol2009-04-06T00:00:002009Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis.22577348Lee HJ, Yu HK, Papadopoulos JN, Kim SW, He J, Park YK, Yoon Y, Kim JS, Kim SJNeoplasia (New York, N.Y.)Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model. Neoplasia. 2012 Apr; 14(4):335-43.Neoplasia2012-04-01T00:00:002012Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model.Authorship 273184216752376Shaw A, Papadopoulos J, Johnson C, Bushman WThe ProstateIsolation and characterization of an immortalized mouse urogenital sinus mesenchyme cell line. Prostate. 2006 Sep 15; 66(13):1347-58.Prostate2006-09-15T00:00:002006Isolation and characterization of an immortalized mouse urogenital sinus mesenchyme cell line.74Professor10Assistant Professor26059275Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim JBJU internationalDisease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016 07; 118(1):68-76.BJU Int2015-07-04T00:00:002015Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.Authorship 37379413Authorship 842719International ImmunopharmacologyConsistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse. International Immunopharmacology. 11:859-869.Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouseD000935Chemicals & Drugs2198340.631958Antifungal AgentsD014516Disorders402280.830011Ureteral NeoplasmsD014230Chemicals & Drugs2606100.706246TriazolesAuthorship 9120668Authorship 9224304Authorship 926632227083967Katz MH, Slack R, Bruno M, McMillan J, Fleming JB, Lee JE, Bednarski B, Papadopoulos J, Matin SFThe Journal of surgical researchOutpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of "TeleDischarge". J Surg Res. 2016 May 01; 202(1):196-203.J Surg Res2016-01-06T00:00:002016Outpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of "TeleDischarge".28731777Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SFJournal of endourologyInduction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes. J Endourol. 2017 09; 31(9):946-953.J Endourol2017-07-21T00:00:002017Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.28458981Hassid VJ, Papadopoulos JNPlastic and reconstructive surgery. Global openPenile Squamous Cell Carcinoma Masquerading as Giant Condyloma. Plast Reconstr Surg Glob Open. 2017 Mar; 5(3):e1269.Plast Reconstr Surg Glob Open2017-03-22T00:00:002017Penile Squamous Cell Carcinoma Masquerading as Giant Condyloma.PathologyPlastic SurgeryUrologyAuthorship 942813530319061Phillips K, Cirrone F, Ahuja T, Siegfried J, Papadopoulos JJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy PractitionersPosaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome. J Oncol Pharm Pract. 2019 Mar; 25(2):398-403.J Oncol Pharm Pract2018-10-14T00:00:002018Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.Authorship 943894529804202Balasubramanian A, Metcalfe MJ, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SFWorld journal of urologySalvage topical therapy for upper tract urothelial carcinoma. World J Urol. 2018 Dec; 36(12):2027-2034.World J Urol2018-05-26T00:00:002018Salvage topical therapy for upper tract urothelial carcinoma.D00007274228540.906807Invasive Fungal InfectionsD065819Chemicals & Drugs501080.931529VoriconazoleAuthorship 10027011533046869Gao J, Navai N, Alhalabi O, Siefker-Radtke A, Campbell MT, Tidwell RS, Guo CC, Kamat AM, Matin SF, Araujo JC, Shah AY, Msaouel P, Corn P, Wang J, Papadopoulos JN, Yadav SS, Blando JM, Duan F, Basu S, Liu W, Shen Y, Zhang Y, Macaluso MD, Wang Y, Chen J, Zhang J, Futreal A, Dinney C, Allison JP, Goswami S, Sharma PNature medicineNeoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat Med. 2020 12; 26(12):1845-1851.Nat Med2020-10-12T00:00:002020Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.Authorship 1012080633612354Kokorovic A, Duplisea J, Qiao W, McCormick B, Adibi M, Papadopoulos J, Ramirez G, Rao P, Tamboli P, Pettaway CUrologic oncologyOncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience. Urol Oncol. 2021 05; 39(5):302.e19-302.e27.Urol Oncol2021-02-18T00:00:002021Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience.Authorship 10300301434536949Spetsieris N, Boukovala M, Alafis I, Davis J, Zurita A, Wang X, Tu SM, Chapin BF, Aparicio A, Corn P, Wang J, Subudhi SK, Araujo J, Papadopoulos J, Pruitt L, Weldon JA, Logothetis CJ, Efstathiou EEuropean journal of cancer (Oxford, England : 1990)Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-na?ve prostate cancer. Eur J Cancer. 2021 11; 157:259-267.Eur J Cancer2021-09-15T00:00:002021Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-na?ve prostate cancer.Authorship 1054706835961847Labbate CV, Hensley PJ, Miest TS, Qiao W, Adibi M, Shah AY, Chery L, Papadopoulos J, Siefker-Radtke AO, Gao J, Guo CC, Czerniak BA, Navai N, Kamat AM, Dinney CP, Campbell MT, Matin SFUrologic oncologyLongitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2022 10; 40(10):454.e17-454.e23.Urol Oncol2022-08-10T00:00:002022Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.Authorship 1087828838262868Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Ch?ry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso PUrologic oncologyThe association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urol Oncol. 2024 Apr; 42(4):116.e1-116.e7.Urol Oncol2024-01-22T00:00:002024The association of body mass index with tumor aggression among men undergoing radical prostatectomy.Authorship 1089468738388244Ozambela M, McCormick BZ, Rudzinski JK, Pieretti AC, Gonz?lez GMN, Meissner MA, Papadopoulos JN, Adibi M, Matin SF, Dahmen AS, Spiess PE, Pettaway CAUrologic oncologyRobotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer. Urol Oncol. 2024 Apr; 42(4):120.e1-120.e9.Urol Oncol2024-02-22T00:00:002024Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer.true1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor